The Earthtimes online News
Home

Arobella Medical CEO is Issued U.S. Patent for Ultrasound Wound Therapy Technology

Posted : Thu, 09 Oct 2008 18:17:33 GMT
Author : Arobella Medical, LLC
Category : Press Release
News Alerts by Email click here )
Create your own RSS
News | Home
Patent will protect next generation of Qoustic Wound Therapy System(R) MINNEAPOLIS, Oct. 9
MINNEAPOLIS, Oct. 9 /PRNewswire/ -- Arobella Medical, LLC, a leader in advanced ultrasonic wound care devices, today announced that its Co-founder, President and CEO Eliaz Babaev, Ph.D., has been issued a U.S. patent that covers technology employed in the next generation of the company's Qoustic Wound Therapy System(R).
The Qoustic Wound Therapy System, which offers a safe, cost-effective alternative to painful sharps debridement and other surgical modalities, is emerging as the gold standard for wound care. Light guidance contact produces a dual delivery of low-frequency ultrasound energy directly on the wound bed. This process gently, thoroughly and efficiently debrides the wound and provides stable cavitation to remove dead or diseased tissue, harmful bacteria and biofilm. Ultrasonic treatment also expedites healing by preserving healthy tissue and protecting granulation tissue, improving circulation through vasodilation and angiogenesis, and preparing the wound bed for more effective use of downstream therapies such as grafts and flaps.
"This patent, which is the first of many that are currently pending, will help protect the next generation of this product that is poised to become the latest breakthrough in wound care today," said Babaev.
The first generation of the Qoustic Wound Therapy System family was launched in February 2008.
About Arobella Medical, LLC
Arobella Medical, LLC is a Minneapolis-based medical device company specializing in low-frequency ultrasound for wound care and other wound management therapies. Arobella Medical is positioned to become a leader in advanced ultrasound wound care technologies and devices. Arobella Medical Co-founder and CEO Eliaz Babaev has more than 40 years of experience developing, designing and commercializing medical devices that use ultrasound, with over 40 patents worldwide. He holds a Ph.D. degree from the Moscow Bauman School, a Doctor of Science degree from the Latvia Academy of Science, and a Doctor of Science degree from the Russian State Supreme Certification Committee, all in biomedical ultrasound. For more information, go to http://www.arobella.com
SOURCE Arobella Medical, LLC

Copyright © 2008 PR Newswire. All rights reserved.




Article : Arobella Medical CEO is Issued U.S. Patent for Ultrasound Wound Therapy Technology
Print this article
Share this article

Stay Updated

News gadget on your Google homepage
Subscribe to a news feed in Google Reader
Share on

Have your Say
Name
Email
Subject
Your Comment

Enter Verification code
 
  

 


Choose Theme
Green Earth Blue Earth Orange Earth Purple Earth

Search
 
You can

Current News

News Category
Business
Entertainment
Environment
General
Health
Sports
Technology
World
Add to Google Toolbar
Breaking News
Press Releases

About us | News Archives | Browse old Archive | Feedback | Disclaimer | Mobile/PDA | News Alerts

The views expressed in the articles are not necessarily those of earthtimes.org and we accept no responsibility for the views or opinions
expressed in the articles either direct or indirect.

© 2009 www.earthtimes.org, The Earth Times, All Rights Reserved | Privacy Policy